X-55003842-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014481.4(APEX2):āc.613A>Gā(p.Ile205Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000545 in 1,209,927 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00012 ( 0 hom., 5 hem., cov: 23)
Exomes š: 0.000048 ( 0 hom. 16 hem. )
Consequence
APEX2
NM_014481.4 missense
NM_014481.4 missense
Scores
2
10
5
Clinical Significance
Conservation
PhyloP100: 4.49
Genes affected
APEX2 (HGNC:17889): (apurinic/apyrimidinic endodeoxyribonuclease 2) Apurinic/apyrimidinic (AP) sites occur frequently in DNA molecules by spontaneous hydrolysis, by DNA damaging agents or by DNA glycosylases that remove specific abnormal bases. AP sites are pre-mutagenic lesions that can prevent normal DNA replication so the cell contains systems to identify and repair such sites. Class II AP endonucleases cleave the phosphodiester backbone 5' to the AP site. This gene encodes a protein shown to have a weak class II AP endonuclease activity. Most of the encoded protein is located in the nucleus but some is also present in mitochondria. This protein may play an important role in both nuclear and mitochondrial base excision repair. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0701392).
BS2
High Hemizygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APEX2 | NM_014481.4 | c.613A>G | p.Ile205Val | missense_variant | 5/6 | ENST00000374987.4 | NP_055296.2 | |
APEX2 | NM_001271748.2 | c.100A>G | p.Ile34Val | missense_variant | 4/5 | NP_001258677.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APEX2 | ENST00000374987.4 | c.613A>G | p.Ile205Val | missense_variant | 5/6 | 1 | NM_014481.4 | ENSP00000364126.3 | ||
APEX2 | ENST00000471758.1 | n.462A>G | non_coding_transcript_exon_variant | 4/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000116 AC: 13AN: 111880Hom.: 0 Cov.: 23 AF XY: 0.000147 AC XY: 5AN XY: 34072
GnomAD3 genomes
AF:
AC:
13
AN:
111880
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
34072
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000126 AC: 23AN: 183144Hom.: 0 AF XY: 0.000118 AC XY: 8AN XY: 67588
GnomAD3 exomes
AF:
AC:
23
AN:
183144
Hom.:
AF XY:
AC XY:
8
AN XY:
67588
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000483 AC: 53AN: 1097992Hom.: 0 Cov.: 30 AF XY: 0.0000440 AC XY: 16AN XY: 363354
GnomAD4 exome
AF:
AC:
53
AN:
1097992
Hom.:
Cov.:
30
AF XY:
AC XY:
16
AN XY:
363354
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000116 AC: 13AN: 111935Hom.: 0 Cov.: 23 AF XY: 0.000146 AC XY: 5AN XY: 34137
GnomAD4 genome
AF:
AC:
13
AN:
111935
Hom.:
Cov.:
23
AF XY:
AC XY:
5
AN XY:
34137
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
13
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.613A>G (p.I205V) alteration is located in exon 5 (coding exon 5) of the APEX2 gene. This alteration results from a A to G substitution at nucleotide position 613, causing the isoleucine (I) at amino acid position 205 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at